SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
This Quarter Return
+16.81%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
10 Year Return
AUM
$268M
AUM Growth
+$268M
Cap. Flow
+$4.07M
Cap. Flow %
1.52%
Top 10 Hldgs %
40.75%
Holding
95
New
14
Increased
33
Reduced
15
Closed
23
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANIP icon
76
ANI Pharmaceuticals
ANIP
$2.03B
-54,041 Closed -$2.91M
BBIO icon
77
BridgeBio Pharma
BBIO
$9.89B
-50,000 Closed -$860K
CLDX icon
78
Celldex Therapeutics
CLDX
$1.47B
-10,000 Closed -$339K
CUE icon
79
Cue Biopharma
CUE
$60M
-403,402 Closed -$1.47M
FGEN icon
80
FibroGen
FGEN
$47.8M
0
GKOS icon
81
Glaukos
GKOS
$5.5B
-1,000 Closed -$71.2K
GLUE icon
82
Monte Rosa Therapeutics
GLUE
$296M
-31,156 Closed -$213K
IMTX icon
83
Immatics
IMTX
$619M
-30,715 Closed -$354K
INCY icon
84
Incyte
INCY
$16.5B
-34,110 Closed -$2.12M
JSPR icon
85
Jasper Therapeutics
JSPR
$45.5M
-500,000 Closed -$685K
MLTX icon
86
MoonLake Immunotherapeutics
MLTX
$3.54B
-200,000 Closed -$10.2M
NUVL icon
87
Nuvalent
NUVL
$5.52B
-115,067 Closed -$4.85M
PHAT icon
88
Phathom Pharmaceuticals
PHAT
$864M
-200,000 Closed -$2.86M
PHVS icon
89
Pharvaris
PHVS
$1.39B
-200,000 Closed -$3.03M
PTGX icon
90
Protagonist Therapeutics
PTGX
$3.67B
-25,000 Closed -$691K
RVPH icon
91
Reviva Pharmaceuticals
RVPH
$30.6M
0
SLRN
92
DELISTED
ACELYRIN
SLRN
0
VKTX icon
93
Viking Therapeutics
VKTX
$3.04B
-258,595 Closed -$4.19M
VTYX icon
94
Ventyx Biosciences
VTYX
$171M
-25,000 Closed -$820K
XBI icon
95
SPDR S&P Biotech ETF
XBI
$5.07B
0